Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Interview with Samuel G. Jacobson, MD, PhD, author of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Episoder(126)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rss-nysgjerrige-norge
rekommandert
forskningno
liberal-halvtime
sinnsyn
vett-og-vitenskap-med-gaute-einevoll
rss-rekommandert
smart-forklart
fjellsportpodden
jss
villmarksliv
pod-britannia
rss-overskuddsliv
rss-radium
nevropodden
hva-er-greia-med
dekodet-2
rss-inn-til-kjernen-med-sunniva-rose